Evolus

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evolus and other ETFs, options, and stocks.

About EOLS

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. 

CEO
David Moatazedi
CEODavid Moatazedi
Employees
334
Employees334
Headquarters
Newport Beach, California
HeadquartersNewport Beach, California
Founded
2012
Founded2012
Employees
334
Employees334

EOLS Key Statistics

Market cap
471.27M
Market cap471.27M
Price-Earnings ratio
-13.55
Price-Earnings ratio-13.55
Dividend yield
—
Dividend yield—
Average volume
660.98K
Average volume660.98K
High today
$7.77
High today$7.77
Low today
$6.91
Low today$6.91
Open price
$7.71
Open price$7.71
Volume
2.07M
Volume2.07M
52 Week high
$9.31
52 Week high$9.31
52 Week low
$3.86
52 Week low$3.86

Stock Snapshot

As of today, Evolus(EOLS) shares are valued at $7.14. The company's market cap stands at 471.27M, with a P/E ratio of -13.55.

On 2026-10-04, Evolus(EOLS) stock moved within a range of $6.91 to $7.77. With shares now at $7.14, the stock is trading +3.3% above its intraday low and -8.1% below the session's peak.

Trading activity shows a volume of 2.07M, compared to an average daily volume of 660.98K.

Over the past 52 weeks, Evolus(EOLS) stock has traded between a high of $9.31 and a low of $3.86.

Over the past 52 weeks, Evolus(EOLS) stock has traded between a high of $9.31 and a low of $3.86.

EOLS News

TipRanks 1d
Evolus Inc Q2 2023 Earnings Report - Results, Call & Slides - TipRanks

...

Evolus Inc Q2 2023 Earnings Report - Results, Call & Slides - TipRanks
Benzinga 1d
Evolus Warned Over Misbranding in Social Media Promo for Frown Lines Drug

The U.S. Food and Drug Administration’s Office of Prescription Drug Promotion in September issued a warning letter to Evolus Inc. (NASDAQ:EOLS) regarding mislea...

Evolus Warned Over Misbranding in Social Media Promo for Frown Lines Drug
TipRanks 3d
Evolus launches Wings by Evolus charitable platform

Evolus (EOLS) announced the launch of Wings by Evolus, a new charitable platform designed to bring together aesthetic practices, providers, and patients to supp...

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own EOLS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.